Sodium Bicarbonate Injection · 3,336 days since initial FDA posting
Brand: SODIUM BICARBONATE
FDA lists Sodium Bicarbonate Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Sodium Bicarbonate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Bicarbonate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)
- Package NDC
- 63323-089-50
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jul 24, 2017
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Nearby, Other Sodium Shortage Records
Sodium Bicarbonate Injection
Fresenius Kabi USA, LLC
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.